Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Wallace, D J
Fortin, P R
Alarcón, G S
Merrill, J T
Hanly, J G
Magder, L S
Dooley, M A
van Vollenhoven, R F
MetadataShow full item record
CitationLupus 2011, 20(3):250-5
AbstractSystemic lupus erythematosus (SLE) is characterized by multiple autoantibodies and complement activation. Recent studies have suggested that anti-nuclear antibody (ANA) positivity may disappear over time in some SLE patients. Anti-double-stranded DNA (dsDNA) antibody titers and complement levels may vary with time and immunosuppressive treatment, while the behavior of anti-extractable nuclear antigen (ENA) over time is less well understood. This study sought to determine the correlation between historical autoantibody tests and current testing in patients with SLE. Three hundred and two SLE patients from the ACR Reclassification of SLE (AROSE) database with both historical and current laboratory data were selected for analysis. The historical laboratory data were compared with the current autoantibody tests done at the reference laboratory and tested for agreement using percent agreement and Kappa statistic. Serologic tests included ANA, anti-dsDNA, anti-Smith, anti-ribonucleoprotein (RNP), anti-Ro, anti-La, rheumatoid factor (RF), C3 and C4. Among those historically negative for immunologic markers, a current assessment of the markers by the reference laboratory generally yielded a low percentage of additional positives (3-13%). However, 6/11 (55%) of those historically negative for ANA were positive by the reference laboratory, and the reference laboratory test also identified 20% more patients with anti-RNP and 18% more with RF. Among those historically positive for immunologic markers, the reference laboratory results were generally positive on the same laboratory test (range 57% to 97%). However, among those with a history of low C3 or C4, the current reference laboratory results indicated low C3 or C4 a low percentage of the time (18% and 39%, respectively). ANA positivity remained positive over time, in contrast to previous studies. Anti-Ro, La, RNP, Smith and anti-dsDNA antibodies had substantial agreement over time, while complement had less agreement. This variation could partially be explained by variability of the historical assays, which were done by local laboratories over varying periods of time. Variation in the results for complement, however, is more likely to be explained by response to treatment. These findings deserve consideration in the context of diagnosis and enrolment in clinical trials.
DescriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links field.
RightsArchived with thanks to Lupus
- [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
- Authors: Horák P, Hermanová Z, Faltýnek L, Pospísil Z, Scudla V
- Issue date: 1997 Oct
- Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus.
- Authors: Hanly JG, Thompson K, McCurdy G, Fougere L, Theriault C, Wilton K
- Issue date: 2010 Jan 31
- Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
- Authors: Pradhan VD, Patwardhan MM, Ghosh K
- Issue date: 2010 Mar-Apr
- Development of autoantibodies before the clinical onset of systemic lupus erythematosus.
- Authors: Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB
- Issue date: 2003 Oct 16
- Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus.
- Authors: Hanly JG, Su L, Farewell V, Fritzler MJ
- Issue date: 2010 Jun 30